What's New in Hair Loss.

Leopoldo Duailibe Nogueira Santos, Jerry Shapiro

Review Dermatologic clinics 2019 7 인용

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D30850035'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

연구 유형: Review
대상 집단: None

중재: What's New in Hair Loss. None
대조군: None
일차 결과: None
효과 방향: Mixed
비뚤림 위험: Unclear

Abstract

The treatment of hair loss is a challenge for all dermatologists. New medications are needed due to lack of efficacy of many treatments or their side-effect profile. This article discusses the most recent literature updates on the use of retinoids in frontal fibrosing alopecia, platelet-rich plasma in androgenetic alopecia, and JAK inhibitors in alopecia areata.

요약

The most recent literature updates on the use of retinoids in frontal fibrosing alopecia, platelet-rich plasma in androgenetic alopEcia, and JAK inhibitors in alopECia areata are discussed.

Used In Evidence Reviews

A PRP 치료 관련 원형 탈모증

A PRP 치료 관련 안드로겐성 탈모

What's New in Hair Loss.

Embed This Widget

Study Design

Abstract

요약

Used In Evidence Reviews

Similar Papers

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.

The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.

Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.

A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.